Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer: Definitive Analysis of NSABP Trial C-10

PURPOSE: Major concerns surround combining chemotherapy with bevacizumab in patients with colon cancer presenting with an asymptomatic intact primary tumor (IPT) and synchronous yet unresectable metastatic disease. Surgical resection of asymptomatic IPT is controversial. PATIENTS AND METHODS: Eligib...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: McCahill, Laurence E., Yothers, Greg, Sharif, Saima, Petrelli, Nicholas J., Lai, Lily Lau, Bechar, Naftali, Giguere, Jeffrey K., Dakhil, Shaker R., Fehrenbacher, Louis, Lopa, Samia H., Wagman, Lawrence D., O'Connell, Michael J., Wolmark, Norman
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434981/
https://ncbi.nlm.nih.gov/pubmed/22869888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.4044
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares